Deeper Dive: Understanding Kiniksa Pharmaceuticals International Plc (KNSA) Through its Various Ratios

Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.

The price of Kiniksa Pharmaceuticals International Plc (NASDAQ: KNSA) closed at $21.27 in the last session, down -0.56% from day before closing price of $21.39. In other words, the price has decreased by -$0.56 from its previous closing price. On the day, 0.73 million shares were traded.

Ratios:

We take a closer look at KNSA’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.34 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 60.81. For the most recent quarter (mrq), Quick Ratio is recorded 3.04 and its Current Ratio is at 3.30. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on September 13, 2024, initiated with a Buy rating and assigned the stock a target price of $40.

On May 03, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $34.

BofA Securities reiterated its Buy rating for the stock on June 29, 2020, while the target price for the stock was revised from $25 to $40.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 10 ’25 when Tessari Eben sold 14,000 shares for $19.57 per share. The transaction valued at 273,980 led to the insider holds 81,975 shares of the business.

Tessari Eben bought 14,000 shares of KNSA for $274,041 on Feb 10 ’25. On Jan 13 ’25, another insider, Tessari Eben, who serves as the CHIEF OPERATING OFFICER of the company, sold 14,000 shares for $18.24 each. As a result, the insider received 255,413 and left with 88,975 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 3.65 while its Price-to-Book (P/B) ratio in mrq is 3.52.

Stock Price History:

Over the past 52 weeks, KNSA has reached a high of $28.15, while it has fallen to a 52-week low of $16.56. The 50-Day Moving Average of the stock is 7.40%, while the 200-Day Moving Average is calculated to be -3.76%.

Shares Statistics:

A total of 41.88M shares are outstanding, with a floating share count of 40.16M. Insiders hold about 44.72% of the company’s shares, while institutions hold 54.48% stake in the company.

Most Popular